These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8378772)

  • 1. Effects of oral administration of type II collagen on rheumatoid arthritis.
    Trentham DE; Dynesius-Trentham RA; Orav EJ; Combitchi D; Lorenzo C; Sewell KL; Hafler DA; Weiner HL
    Science; 1993 Sep; 261(5129):1727-30. PubMed ID: 8378772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial.
    Häuselmann HJ; Caravatti M; Seifert B; Wang K; Bruckner P; Stucki G; Michel BA
    Br J Rheumatol; 1998 Oct; 37(10):1110-7. PubMed ID: 9825751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.
    Barnett ML; Kremer JM; St Clair EW; Clegg DO; Furst D; Weisman M; Fletcher MJ; Chasan-Taber S; Finger E; Morales A; Le CH; Trentham DE
    Arthritis Rheum; 1998 Feb; 41(2):290-7. PubMed ID: 9485087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating arthritis with tolerance.
    Barinaga M
    Science; 1993 Sep; 261(5129):1669-70. PubMed ID: 8378767
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis.
    Londei M; Savill CM; Verhoef A; Brennan F; Leech ZA; Duance V; Maini RN; Feldmann M
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):636-40. PubMed ID: 2463633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Collagen in the treatment of rheumatic diseases--oral tolerance].
    Stancikova M; Stancik R; Gubzova Z; Rovensky J
    Bratisl Lek Listy; 1999; 100(10):567-71. PubMed ID: 10649854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial.
    Sieper J; Kary S; Sörensen H; Alten R; Eggens U; Hüge W; Hiepe F; Kühne A; Listing J; Ulbrich N; Braun J; Zink A; Mitchison NA
    Arthritis Rheum; 1996 Jan; 39(1):41-51. PubMed ID: 8546737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral tolerance in the treatment of rheumatoid arthritis.
    Toussirot EA
    Curr Drug Targets Inflamm Allergy; 2002 Mar; 1(1):45-52. PubMed ID: 14561205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis.
    McKown KM; Carbone LD; Kaplan SB; Aelion JA; Lohr KM; Cremer MA; Bustillo J; Gonzalez M; Kaeley G; Steere EL; Somes GW; Myers LK; Seyer JM; Kang AH; Postlethwaite AE
    Arthritis Rheum; 1999 Jun; 42(6):1204-8. PubMed ID: 10366113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral toleragens in rheumatoid arthritis.
    Choy EH
    Curr Opin Investig Drugs; 2000 Sep; 1(1):58-62. PubMed ID: 11249596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral type II collagen in the treatment of rheumatoid arthritis. A six-month double blind placebo-controlled study.
    Cazzola M; Antivalle M; Sarzi-Puttini P; Dell'Acqua D; Panni B; Caruso I
    Clin Exp Rheumatol; 2000; 18(5):571-7. PubMed ID: 11072596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy with oral type II collagen as a new possibility of selective immunosuppression in therapy of rheumatoid arthritis].
    Sieper J; Mitchison AN
    Z Rheumatol; 1994; 53(2):53-8. PubMed ID: 8023585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between HLA-DRB1 genotypes and efficacy of oral type II collagen treatment using chicken cartilage soup in rheumatoid arthritis].
    Toda Y; Takemura S; Morimoto T; Ogawa R
    Nihon Rinsho Meneki Gakkai Kaishi; 1997 Feb; 20(1):44-51. PubMed ID: 9105164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.
    Garcia G; Komagata Y; Slavin AJ; Maron R; Weiner HL
    J Autoimmun; 1999 Nov; 13(3):315-24. PubMed ID: 10550219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration.
    Bagchi D; Misner B; Bagchi M; Kothari SC; Downs BW; Fafard RD; Preuss HG
    Int J Clin Pharmacol Res; 2002; 22(3-4):101-10. PubMed ID: 12837047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial.
    Koffeman EC; Genovese M; Amox D; Keogh E; Santana E; Matteson EL; Kavanaugh A; Molitor JA; Schiff MH; Posever JO; Bathon JM; Kivitz AJ; Samodal R; Belardi F; Dennehey C; van den Broek T; van Wijk F; Zhang X; Zieseniss P; Le T; Prakken BA; Cutter GC; Albani S
    Arthritis Rheum; 2009 Nov; 60(11):3207-16. PubMed ID: 19877047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral desensitization in the treatment of human immune diseases.
    Vischer TL
    Z Rheumatol; 1995; 54(3):155-7. PubMed ID: 7544938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tolerance in the control of experimental models of autoimmune disease.
    Staines NA; Harper N
    Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.